DEBEL MARLENE has filed 39 insider transactions across 2 companies since February 2023.
Most recent transaction: a tax payment of 4133 shares of METLIFE INC ($MET) on March 02, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | F | Common Stock | 4133 | $73.24 | 154,380.0000 | 673,300,000 | 2.61% | 0.00% |
| Feb. 24, 2026 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | F | Common Stock | 5624 | $75.34 | 158,513.0000 | 673,300,000 | 3.43% | 0.00% |
| Feb. 24, 2026 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 14870 | $0.00 | 164,137.0000 | 673,300,000 | 9.96% | 0.00% |
| Feb. 24, 2026 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 15132 | $0.00 | 149,267.0000 | 673,300,000 | 11.28% | 0.00% |
| Feb. 19, 2026 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | A | Restricted Stock Units | 1303 | $0.00 | 2,556.0000 | 201,400,000 | 103.99% | 0.00% |
| Feb. 19, 2026 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | M | Restricted Stock Units | 1253 | $0.00 | 1,303.0000 | 201,400,000 | 49.02% | 0.00% |
| Feb. 19, 2026 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | M | Common Stock | 1253 | $0.00 | 8,820.0000 | 201,400,000 | 16.56% | 0.00% |
| March 3, 2025 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | F | Common Stock | 2866 | $85.70 | 134,135.0000 | 711,100,000 | 2.09% | 0.00% |
| Feb. 25, 2025 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 12774 | $0.00 | 121,281.0000 | 711,100,000 | 11.77% | 0.00% |
| Feb. 25, 2025 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 28426 | $0.00 | 149,707.0000 | 711,100,000 | 23.44% | 0.00% |
| Feb. 25, 2025 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | F | Common Stock | 12706 | $82.20 | 137,001.0000 | 711,100,000 | 8.49% | 0.00% |
| Feb. 20, 2025 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | M | Common Stock | 1711 | $0.00 | 7,567.0000 | 209,200,000 | 29.22% | 0.00% |
| Feb. 20, 2025 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | M | Restricted Stock Units | 1711 | $0.00 | 1,253.0000 | 209,200,000 | 57.73% | 0.00% |
| Feb. 20, 2025 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | A | Restricted Stock Units | 1253 | $0.00 | 2,964.0000 | 209,200,000 | 73.23% | 0.00% |
| Dec. 13, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | M | Employee Stock Options (right to buy) | 9703 | $0.00 | 0.0000 | 715,500,000 | 100.00% | 0.00% |
| Dec. 13, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | M | Employee Stock Options (right to buy) | 13107 | $0.00 | 0.0000 | 715,500,000 | 100.00% | 0.00% |
| Dec. 13, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | S | Common Stock | 22810 | $82.88 | 108,507.0000 | 715,500,000 | 17.37% | 0.00% |
| Dec. 13, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | M | Common Stock | 9703 | $45.91 | 131,317.0000 | 715,500,000 | 7.98% | 0.00% |
| Dec. 13, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | M | Common Stock | 13107 | $34.33 | 121,614.0000 | 715,500,000 | 12.08% | 0.00% |
| March 1, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | F | Common Stock | 2741 | $69.73 | 108,507.0000 | 762,300,000 | 2.46% | 0.00% |
| Feb. 27, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | F | Common Stock | 16206 | $69.16 | 111,248.0000 | 762,300,000 | 12.72% | 0.00% |
| Feb. 27, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Employee Stock Options (right to buy) | 17896 | $0.00 | 17,896.0000 | 762,300,000 | 9999.99% | 0.00% |
| Feb. 27, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 5965 | $0.00 | 91,497.0000 | 762,300,000 | 6.97% | 0.00% |
| Feb. 27, 2024 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 35957 | $0.00 | 127,454.0000 | 762,300,000 | 39.30% | 0.00% |
| Feb. 22, 2024 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | M | Restricted Stock Units | 1643 | $0.00 | 1,711.0000 | 216,900,000 | 48.99% | 0.00% |
| Feb. 22, 2024 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | M | Common Stock | 1643 | $0.00 | 5,856.0000 | 216,900,000 | 39.00% | 0.00% |
| Feb. 22, 2024 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | A | Restricted Stock Units | 1711 | $0.00 | 3,354.0000 | 216,900,000 | 104.14% | 0.00% |
| Aug. 31, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 7894 | $0.00 | 85,532.0000 | 808,900,000 | 10.17% | 0.00% |
| Aug. 9, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | S | Common Stock | 9391 | $63.18 | 77,638.0000 | 808,900,000 | 10.79% | 0.00% |
| Aug. 9, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | M | Employee Stock Options (right to buy) | 10911 | $0.00 | 0.0000 | 808,900,000 | 100.00% | 0.00% |
| Aug. 9, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | M | Common Stock | 10911 | $45.15 | 87,029.0000 | 808,900,000 | 14.33% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | F | Common Stock | 14368 | $71.73 | 78,666.0000 | 808,900,000 | 15.44% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Employee Stock Options (right to buy) | 16625 | $0.00 | 16,625.0000 | 808,900,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 5542 | $0.00 | 60,841.0000 | 808,900,000 | 10.02% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | A | Common Stock | 32193 | $0.00 | 93,034.0000 | 808,900,000 | 52.91% | 0.00% |
| March 1, 2023 | METLIFE INC | $MET | DEBEL MARLENE | EVP & Chief Risk Officer | F | Common Stock | 2548 | $71.27 | 76,118.0000 | 808,900,000 | 3.24% | 0.00% |
| Feb. 23, 2023 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | M | Common Stock | 1683 | $0.00 | 4,213.0000 | 0 | 66.52% | 0.00% |
| Feb. 23, 2023 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | M | Restricted Stock Units | 1683 | $0.00 | 1,643.0000 | 0 | 50.60% | 0.00% |
| Feb. 23, 2023 | RAYMOND JAMES FINANCIAL INC | $RJF | DEBEL MARLENE | Director | A | Restricted Stock Units | 1643 | $0.00 | 3,326.0000 | 0 | 97.62% | 0.00% |